fosmidomycin has been researched along with Koch's Disease in 1 studies
fosmidomycin: from Streptomyces lavendulae; RN given refers to parent cpd; structure in second source
fosmidomycin : Propylphosphonic acid in which one of the hydrogens at position 3 is substituted by a formyl(hydroxy)amino group. An antibiotic obtained from Streptomyces lavendulae, it specifically inhibits DXP reductoisomerase (EC 1.1.1.267), a key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fosmidomycin is a natural antibiotic with potent IspC (DXR, 1-deoxy-d-xylulose-5-phosphate reductoisomerase) inhibitory activity." | 1.91 | Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents. ( Caljon, G; Coenye, T; Cos, P; Courtens, C; Quennesson, T; Risseeuw, M; Van Calenbergh, S; van Charante, F, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Courtens, C | 3 |
| van Charante, F | 3 |
| Quennesson, T | 3 |
| Risseeuw, M | 3 |
| Cos, P | 3 |
| Caljon, G | 3 |
| Coenye, T | 3 |
| Van Calenbergh, S | 3 |
1 other study available for fosmidomycin and Koch's Disease
| Article | Year |
|---|---|
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |
Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents.
Topics: Anti-Bacterial Agents; Antimalarials; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mycobacte | 2023 |